Cargando…
Engineered Salmonella enterica serovar Typhimurium overcomes limitations of anti-bacterial immunity in bacteria-mediated tumor therapy
Cancer is one of the leading causes of death in the industrialized world and represents a tremendous social and economic burden. As conventional therapies fail to provide a sustainable cure for most cancer patients, the emerging unique immune therapeutic approach of bacteria-mediated tumor therapy (...
Autores principales: | Felgner, Sebastian, Kocijancic, Dino, Frahm, Michael, Heise, Ulrike, Rohde, Manfred, Zimmermann, Kurt, Falk, Christine, Erhardt, Marc, Weiss, Siegfried |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749626/ https://www.ncbi.nlm.nih.gov/pubmed/29308303 http://dx.doi.org/10.1080/2162402X.2017.1382791 |
Ejemplares similares
-
Efficiency of Conditionally Attenuated Salmonella enterica Serovar Typhimurium in Bacterium-Mediated Tumor Therapy
por: Frahm, Michael, et al.
Publicado: (2015) -
aroA-Deficient Salmonella enterica Serovar Typhimurium Is More Than a Metabolically Attenuated Mutant
por: Felgner, Sebastian, et al.
Publicado: (2016) -
Characterization of Novel Factors Involved in Swimming and Swarming Motility in Salmonella enterica Serovar Typhimurium
por: Deditius, Julia Andrea, et al.
Publicado: (2015) -
Regulation of Flagellum Biosynthesis in Response to Cell Envelope Stress in Salmonella enterica Serovar Typhimurium
por: Spöring, Imke, et al.
Publicado: (2018) -
Local application of bacteria improves safety of Salmonella-mediated tumor therapy and retains advantages of systemic infection
por: Kocijancic, Dino, et al.
Publicado: (2017)